Before the pandemic, the challenges plaguing U.S. healthcare seemed insurmountable. Think onerous regulations, outdated processes, and high prices. But the dark clouds of the crisis are bringing silver linings - less red tape, virtual access to doctors, and long-awaited innovation. How are healthcare providers adapting? And what role will Big Tech play? Kennen MacKay, RBC Capital Markets' Co-Head of Biotechnology Research, shares how changes in the U.S. healthcare sector are here to stay.

For more insights about social, economic and technological trends, visit rbc.com/thoughtleadership.